Initial studies in mice and later in patients with type 2 diabetes mellitus showed that AZD8601, a modified mRNA encoding vascular endothelial growth factor (VEGF), improved wound healing in diabetic wound models in mice and increased skin blood flow in patients.43 Here, VEGFA is linked to type 2 diabetes mellitus.